Table 4.
Potential TAFLD/TASH mechanisms.
| Hepatocellular necrosis | Altered hepatic lipid metabolism |
| Lipotoxicity | Proinflammatory cytokines |
| Insulin resistance with altered adipokines |
Oxidative stress with decreased antioxidant levels |
| Mitochondrial dysfunction | Metabolic endotoxemia |
| Endoplasmic reticulum stress | Proteasomal dysfunction |
| Altered transmethylation/ transulfuration |
Decreased intestinal barrier function |
| Autophagy | Altered intestinal microflora |
| Nuclear receptor activation | Nutrient-toxicant interactions |
| Kupffer cell activation | Liver sinusoidal endothelial cell damage |
| Carbonyl stress | Priming and Sensitization |
| Epigenetic modifications | Hypoxia |
Note: TAFLD = toxicant-associated fatty liver disease; TASH = toxicant-associated steatohepatitis.